Hormone receptor-positive early breast cancer in young women: A comprehensive review

被引：4

作者：

Walbaum, Benjamin ^{[1
,2
,3
]}

Garcia-Fructuoso, Isabel ^{[1
,2
]}

Martinez-Saez, Olga ^{[1
,2
]}

Schettini, Francesco ^{[1
,2
]}

Sanchez, Cesar ^{[3
,4
]}

Acevedo, Francisco ^{[3
,4
]}

Chic, Nuria ^{[1
,2
]}

Munoz-Carrillo, Javier ^{[2
]}

Adamo, Barbara ^{[1
,2
]}

Munoz, Montserrat ^{[1
,2
,7
]}

Partridge, Ann H. ^{[5
,6
,7
]}

Bellet, Meritxell ^{[8
,9
]}

Braso-Maristany, Fara ^{[1
,10
,11
]}

Prat, Aleix ^{[1
,10
,11
,12
,13
]}

Vidal, Maria ^{[1
,2
,11
,12
,13
]}

机构：

[1] Hosp Clin Barcelona, August Pi I Sunyer Biomed Res Inst, Dept Med Oncol, Translat Genom & Targeted Therapies Solid Tumors G, Barcelona, Spain

[2] Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain

[3] Pontificia Univ Catolica Chile, Dept Med Oncol, Santiago, Chile

[4] Univ Catolica Chile, Fac Med, Santiago, Chile

[5] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA

[6] Dana Farber Brigham Canc Ctr, Breast Oncol Program, Boston, MA USA

[7] Harvard Med Sch, Boston, MA USA

[8] Vall dHebron Univ Hosp, Oncol Dept, Breast Canc Unit, Barcelona, Spain

[9] Vall dHebron Inst Oncol, Barcelona, Spain

[10] Hosp Clin Barcelona, Inst Canc & Blood Disorders, Barcelona, Spain

[11] Reveal Genom, Barcelona, Spain

[12] Hosp Quironsalud, Inst Oncol IOB, Barcelona, Spain

[13] Univ Barcelona, Fac Med & Hlth Sci, Barcelona, Spain

来源：

CANCER TREATMENT REVIEWS | 2024年 / 129卷

关键词：

Young women; Early breast cancer; Hormone receptor-positive; Biomarkers; Prognosis; Genomic-signatures; INTERNATIONAL CONSENSUS GUIDELINES; ENDOCRINE THERAPY; PREMENOPAUSAL PATIENTS; FERTILITY PRESERVATION; ADJUVANT CHEMOTHERAPY; MOLECULAR PORTRAITS; OVARIAN SUPPRESSION; TAMOXIFEN; DIAGNOSIS; AGE;

D O I：

10.1016/j.ctrv.2024.102804

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The incidence of breast cancer in <= 40 yr-old women (YWBC) has been steadily increasing in recent decades. Although this group of patients represents less than 10 % of all newly diagnosed BC cases it encompasses a significant burden of disease. Usually underrepresented in clinical trials, YWBCs are also characterized by late diagnoses and poorly differentiated, aggressive-subtype disease, partly explaining its poor prognosis along with a high recurrence risk, and high mortality rates. On the other hand, YWBC treatment poses unique challenges such as preservation of fertility, and long-term toxicity and adverse events. Herein, we summarize the current evidence in hormone receptor-positive YWBC including specific risk factors, clinicopathologic and genomic features, and available evidence on response to chemotherapy and endocrine therapy. Overall, we advocate for a more comprehensive multidisciplinary healthcare model to improve the outcomes and the quality of life of this subset of younger patients.

引用

页数：12

共 123 条

[71] Genomic characterisation of hormone receptor-positive breast cancer arising in very young women [J].

Luen, S. J. ;

Viale, G. ;

Nik-Zainal, S. ;

Savas, P. ;

Kammler, R. ;

Dell'Orto, P. ;

Biasi, O. ;

Degasperi, A. ;

Brown, L. C. ;

Lang, I. ;

MacGrogan, G. ;

Tondini, C. ;

Bellet, M. ;

Villa, F. ;

Bernardo, A. ;

Ciruelos, E. ;

Karlsson, P. ;

Neven, P. ;

Climent, M. ;

Mueller, B. ;

Jochum, W. ;

Bonnefoi, H. ;

Martino, S. ;

Davidson, N. E. ;

Geyer, C. ;

Chia, S. K. ;

Ingle, J. N. ;

Coleman, R. ;

Solbach, C. ;

Thurlimann, B. ;

Colleoni, M. ;

Coates, A. S. ;

Goldhirsch, A. ;

Fleming, G. F. ;

Francis, P. A. ;

Speed, T. P. ;

Regan, M. M. ;

Loi, S. .

ANNALS OF ONCOLOGY, 2023, 34 (04) :397-409

[72] Breast Cancer-Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies-An Updated Review [J].

Lukasiewicz, Sergiusz ;

Czeczelewski, Marcin ;

Forma, Alicja ;

Baj, Jacek ;

Sitarz, Robert ;

Stanislawek, Andrzej .

CANCERS, 2021, 13 (17)

[73] Selection of appropriate biomarkers to monitor effectiveness of ovarian function suppression in pre-menopausal patients with ER+ breast cancer [J].

Mccann, Kelly E. ;

Goldfarb, Shari B. ;

Traina, Tiffany A. ;

Regan, Meredith M. ;

Vidula, Neelima ;

Kaklamani, Virginia .

NPJ BREAST CANCER, 2024, 10 (01)

[74]

Muñoz M, 2020, LANCET ONCOL, V21, P1390, DOI 10.1016/S1470-2045(20)30478-2

[75]

Munoz-Carrillo, 2023, PO2-01-13 Clinico-Pathological and Molecular Characterization of Early Hormone Receptor-Positive Breast Cancer in Young Women

[76] Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review [J].

Murphy, Caitlin C. ;

Bartholomew, L. Kay ;

Carpentier, Melissa Y. ;

Bluethmann, Shirley M. ;

Vernon, Sally W. .

BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (02) :459-478

[77] Peripheral blood TCR clonotype diversity as an age- associated marker of breast cancer progression [J].

Nishida, Jun ;

Cristea, Simona ;

Bodapati, Sudheshna ;

Puleo, Julieann ;

Bai, Gali ;

Patel, Ashka ;

Hughes, Melissa ;

Snow, Craig ;

Borges, Virginia ;

Ruddy, Kathryn J. ;

Collins, Laura C. ;

Feeney, Anne-Marie ;

Slowik, Kara ;

Bossuyt, Veerle ;

Dillon, Deborah ;

Lin, Nancy U. ;

Partridge, Ann H. ;

Michor, Franziska ;

Polyak, Kornelia .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, 120 (49)

[78]

Nitz U, SAN ANTONIO BREAST C

[79] Endocrine Therapy Response and 21-Gene Expression Assay for Therapy Guidance in HR+/HP2-Early Breast Cancer [J].

Nitz, Ulrike A. ;

Gluz, Oleg ;

Kuemmel, Sherko ;

Christgen, Matthias ;

Braun, Michael ;

Aktas, Bahriye ;

Luedtke-Heckenkamp, Kerstin ;

Forstbauer, Helmut ;

Grischke, Eva-Maria ;

Schumacher, Claudia ;

Darsow, Maren ;

Krauss, Katja ;

Nuding, Benno ;

Thill, Marc ;

Potenberg, Jochem ;

Uleer, Christoph ;

Warm, Mathias ;

Fischer, Hans Holger ;

Malter, Wolfram ;

Hauptmann, Michael ;

Kates, Ronald E. ;

Graeser, Monika ;

Wuerstlein, Rachel ;

Shak, Steven ;

Baehner, Frederick ;

Kreipe, Hans H. ;

Harbeck, Nadia .

JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (23) :2557-+

[80] RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers [J].

Nolan, Emma ;

Vaillant, Francois ;

Branstetter, Daniel ;

Pal, Bhupinder ;

Giner, Goeknur ;

Whitehead, Lachlan ;

Lok, Sheau W. ;

Mann, Gregory B. ;

Rohrbach, Kathy ;

Huang, Li-Ya ;

Soriano, Rosalia ;

Smyth, Gordon K. ;

Dougall, William C. ;

Visvader, Jane E. ;

Lindeman, Geoffrey J. .

NATURE MEDICINE, 2016, 22 (08) :933-+

← 3 4 5 6 7 8 9 10 11 12 →